Bio-Sourcing Launches €3.4M EU-Funded Program for Biotherapeutics Development

Bio-Sourcing, a Belgian biotech firm, initiates a project to develop oral antibody treatment for Inflammatory Bowel Diseases and systemic immunology indications with a €3.4M EU-funded program. The aim is to create a cost-effective alternative to current subcutaneous injections, making essential medicines more accessible.